Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Clovis Oncology	Axovant Sciences	Neoleukin Therapeutics	Viking Therapeutics	BioDelivery Sciences International
Symbol	NASDAQ:CLVS	NASDAQ:AXON	NASDAQ:NLTX	NASDAQ:VKTX	NASDAQ:BDSI
Price Information
Current Price	$10.46	$4.25	$10.71	$6.94	$5.35
52 Week Range	Hold	Buy	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Hold	Buy	Buy	Buy	Buy
Consensus Price Target	$19.91	$32.00	$20.00	$18.76	$8.00
% Upside from Price Target	90.34% upside	652.94% upside	86.74% upside	170.35% upside	49.53% upside
Trade Information
Market Cap	$573.37 million	$519.69 million	$520.75 million	$486.33 million	$483.79 million
Beta	3.31	1.21	-6.92	2.35	0.52
Average Volume	7,812,303	1,450,955	412,837	997,222	1,060,509
Sales & Book Value
Annual Revenue	$95.39 million	N/A	$25 million	N/A	$55.64 million
Price / Sales	6.01	N/A	20.83	N/A	8.61
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.78 per share	$0.19 per share	$3.09 per share	$4.17 per share	$0.42 per share
Price / Book	3.76	N/A	3.47	N/A	12.74
Profitability
Net Income	$-368,010,000.00	$-221,570,000.00	$-31,580,000.00	$-22,060,000.00	$-33,870,000.00
EPS	($7.07)	($2.06)	($1.34)	($0.40)	($0.73)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	17.83
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-298.53%	N/A	N/A	N/A	-22.11%
Return on Equity (ROE)	-1,576.32%	-416.05%	-26.13%	-8.10%	-8.80%
Return on Assets (ROA)	-53.65%	-124.55%	-24.97%	-7.94%	-3.02%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	1.24%	0.01%	N/A	0.86%
Current Ratio	3.76%	2.02%	26.35%	46.71%	2.25%
Quick Ratio	3.53%	2.02%	26.35%	46.71%	2.02%
Ownership Information
Institutional Ownership Percentage	96.49%	7.58%	38.43%	54.10%	70.22%
Insider Ownership Percentage	8.30%	6.00%	4.00%	3.49%	8.94%
Miscellaneous
Employees	N/A	N/A	8	15	164
Shares Outstanding	54.82 million	122.28 million	48.62 million	72.26 million	89.52 million
Next Earnings Date	2/24/2020 (Confirmed)	N/A	3/5/2020 (Estimated)	3/11/2020 (Estimated)	3/12/2020 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources